By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each event and how to register is found below.

Oncology webinar hosted by H.C. Andersen Capital, May 31 at 10:00 CET
Virtual
ExpreS[2]ion VP of Preclinical Development Mette Thorn and CFO Keith Alexander will provide an update on ExpreS[2]ion's HER2+ therapeutic breast cancer vaccine program and answer participants' questions. More information and registration can be found on the H.C. Andersen Capital events website (https://hcandersencapital.dk/event/oncology-seminar/).

Presentation of Q1 2022 results hosted by H.C. Andersen Capital, June 9 at 13:00 CET
Virtual
ExpreS[2]ion CEO Bent U. Frandsen will discuss the Q1 2022 results and answer investors' questions. More information and registration can be found on the H.C. Andersen Capital events website (https://hcandersencapital.dk/event/expres2ion-biotechnologies-presentation-of-q1-report-2022/).

ECI Vaccine Technology VIII Conference, June 12-17
Sitges, Spain
Meet our scientists at the leading conference focused on the discovery, development and manufacture of vaccines, hosted by ECI. More information and registration can be found on the ECI website (http://engconf.us/conferences/biotechnology/vaccine-technology-viii/).

BIO International Convention, June 13-16
San Diego, CA, USA
Meet ExpreS[2]ion CEO, Bent Frandsen, at the largest global biotechnology industry event. More information and registration can be found on the BIO website (https://www.bio.org/events/bio-international-convention).

Certified Adviser
Svensk Kapitalmarknadsgranskning AB
Telefon: +46 11 32 30 732
E-post: ca@skmg.se